Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
03 2020
Historique:
received: 28 08 2019
revised: 20 11 2019
accepted: 02 12 2019
pubmed: 16 1 2020
medline: 22 8 2020
entrez: 16 1 2020
Statut: ppublish

Résumé

There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, a known pathological process of FTD, but has yet to be explored as potential biomarker. Plasma GFAP and neurofilament light chain (NfL) concentration were measured in 469 individuals enrolled in the Genetic FTD Initiative: 114 Plasma GFAP concentration was significantly increased in symptomatic Raised GFAP concentrations appear to be unique to

Sections du résumé

BACKGROUND
There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, a known pathological process of FTD, but has yet to be explored as potential biomarker.
METHODS
Plasma GFAP and neurofilament light chain (NfL) concentration were measured in 469 individuals enrolled in the Genetic FTD Initiative: 114
RESULTS
Plasma GFAP concentration was significantly increased in symptomatic
CONCLUSIONS
Raised GFAP concentrations appear to be unique to

Identifiants

pubmed: 31937580
pii: jnnp-2019-321954
doi: 10.1136/jnnp-2019-321954
doi:

Substances chimiques

Biomarkers 0
C9orf72 Protein 0
C9orf72 protein, human 0
GRN protein, human 0
Glial Fibrillary Acidic Protein 0
MAPT protein, human 0
Neurofilament Proteins 0
Progranulins 0
tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

263-270

Subventions

Organisme : Medical Research Council
ID : MC_U123160651
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008525/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M023664/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 103838
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K010395/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M018288/1
Pays : United Kingdom

Investigateurs

Martin N Rossor (MN)
Jason D Warren (JD)
Nick C Fox (NC)
Rita Guerreiro (R)
Jose Bras (J)
Jennifer Nicholas (J)
Simon Mead (S)
Lize Jiskoot (L)
Lieke Meeter (L)
Jessica Panman (J)
Janne Papma (J)
Rick van Minkelen (RV)
Yolanda Pijnenburg (Y)
Myriam Barandiaran (M)
Begoña Indakoetxea (B)
Alazne Gabilondo (A)
Mikel Tainta (M)
Maria de Arriba (M)
Ana Gorostidi (A)
Miren Zulaica (M)
Jorge Villanua (J)
Zigor Diaz (Z)
Sergi Borrego-Ecija (S)
Jaume Olives (J)
Albert Lladó (A)
Mircea Balasa (M)
Anna Antonell (A)
Nuria Bargallo (N)
Enrico Premi (E)
Maura Cosseddu (M)
Stefano Gazzina (S)
Alessandro Padovani (A)
Roberto Gasparotti (R)
Silvana Archetti (S)
Sandra Black (S)
Sara Mitchell (S)
Ekaterina Rogaeva (E)
Morris Freedman (M)
Ron Keren (R)
David Tang-Wai (D)
Linn Öijerstedt (L)
Christin Andersson (C)
Vesna Jelic (V)
Hakan Thonberg (H)
Andrea Arighi (A)
Chiara Fenoglio (C)
Elio Scarpini (E)
Giorgio Fumagalli (G)
Thomas Cope (T)
Carolyn Timberlake (C)
Timothy Rittman (T)
Christen Shoesmith (C)
Robart Bartha (R)
Rosa Rademakers (R)
Carlo Wilke (C)
Hans-Otto Karnarth (HO)
Benjamin Bender (B)
Rose Bruffaerts (R)
Philip Vandamme (P)
Mathieu Vandenbulcke (M)
Catarina B Ferreira (CB)
Gabriel Miltenberger (G)
Carolina Maruta (C)
Ana Verdelho (A)
Sónia Afonso (S)
Ricardo Taipa (R)
Paola Caroppo (P)
Giuseppe Di Fede (GD)
Giorgio Giaccone (G)
Sara Prioni (S)
Veronica Redaelli (V)
Giacomina Rossi (G)
Pietro Tiraboschi (P)
Diana Duro (D)
Maria Rosario Almeida (MR)
Miguel Castelo-Branco (M)
Maria João Leitão (MJ)
Miguel Tabuas-Pereira (M)
Beatriz Santiago (B)
Serge Gauthier (S)
Pedro Rosa-Neto (P)
Michele Veldsman (M)
Toby Flanagan (T)
Catharina Prix (C)
Tobias Hoegen (T)
Elisabeth Wlasich (E)
Sandra Loosli (S)
Sonja Schonecker (S)
Elisa Semler (E)
Sarah Anderl-Straub (S)
Luisa Benussi (L)
Giuliano Binetti (G)
Roberta Ghidoni (R)
Michela Pievani (M)
Gemma Lombardi (G)
Benedetta Nacmias (B)
Camilla Ferrari (C)
Valentina Bessi (V)

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Carolin Heller (C)

UK Dementia Research Institute, Department of Neurodegenerative Disease, University College London, London, UK.

Martha S Foiani (MS)

UK Dementia Research Institute, Department of Neurodegenerative Disease, University College London, London, UK.

Katrina Moore (K)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

Rhian Convery (R)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

Martina Bocchetta (M)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

Mollie Neason (M)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

David M Cash (DM)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Centre for Medical Image Computing, University College London, London, UK.

David Thomas (D)

Neuradiological Academic Unit, UCL Queen Square Institute of Neurology, London, UK.

Caroline V Greaves (CV)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

Ione Oc Woollacott (IO)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

Rachelle Shafei (R)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.

John C Van Swieten (JC)

Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Fermin Moreno (F)

Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, País Vasco, Spain.

Raquel Sanchez-Valle (R)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Barcelona, Spain.

Barbara Borroni (B)

Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Robert Laforce (R)

Clinique Interdisciplinaire de Mémoire du CHU de Québec, Département des Sciences Neurologiques, Université Laval, Québec, Québec, Canada.

Mario Masellis (M)

Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.

Maria Carmela Tartaglia (MC)

Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada.

Caroline Graff (C)

Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden.

Daniela Galimberti (D)

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Centro Dino Ferrari, Milan, Italy.
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

James B Rowe (JB)

Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Elizabeth Finger (E)

Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
German Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany.

Rik Vandenberghe (R)

Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.

Alexandre de Mendonca (A)

Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Fabrizio Tagliavini (F)

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Neurologico Carlo Besta, Milan, Italy.

Isabel Santana (I)

Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Simon Ducharme (S)

Department of Neurology and Neurosurgery, McGill University, Montreal, Québec, Canada.

Christopher R Butler (CR)

Department of Clinical Neurology, University of Oxford, Oxford, UK.

Alex Gerhard (A)

Faculty of Medical and Human Sciences, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.

Johannes Levin (J)

German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Adrian Danek (A)

Department of Neurology, Ludwig-Maximilians-University, Munich, Germany.

Giovanni Frisoni (G)

IRCCS San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

Sandro Sorbi (S)

Department of Neuroscience, Psychology, Drug Research, and Child Health, University of Florence, Florence, Italy.

Markus Otto (M)

Department of Neurology, University of Ulm, Ulm, Germany.

Amanda J Heslegrave (AJ)

UK Dementia Research Institute, Department of Neurodegenerative Disease, University College London, London, UK.

Henrik Zetterberg (H)

UK Dementia Research Institute, Department of Neurodegenerative Disease, University College London, London, UK.
Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

Jonathan D Rohrer (JD)

Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK j.rohrer@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH